{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-008461","form_type":"8-K","ticker":"ALXO","cik":"0001810182","company_name":"ALX ONCOLOGY HOLDINGS INC","filed_at":"2025-01-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.972720+00:00","generated_at":"2026-05-27T23:21:53.717961+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"ALX Oncology adopts 2025 Inducement Plan, reserves 1.5M shares for new-hire equity awards","bullets":["Board approved Inducement Plan on Jan 16, 2025; effective immediately.","1,500,000 shares of common stock reserved for issuance under the plan.","Awards are limited to new employees as a material inducement to join the company, per Nasdaq Listing Rule 5635(c)(4).","Plan terms are substantially similar to ALX's existing 2020 Equity Incentive Plan.","No shareholder approval was required for adoption."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-008461","json":"https://secwatch.observer/filing/0001193125-25-008461.json","markdown":"https://secwatch.observer/filing/0001193125-25-008461.md","text":"https://secwatch.observer/filing/0001193125-25-008461.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810182/000119312525008461/0001193125-25-008461-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810182/000119312525008461/d909443d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T23:21:53.717961+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}